Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-C motif chemokine receptor 1 (XCR1) is the sole member of the "C" sub-family of chemokine receptors, functioning as a G protein-coupled receptor that binds the chemokines XCL1 and XCL2 (lymphotactin-1 and -2). It is expressed primarily on a specialized subset of dendritic cells (DCs), specifically CD8α+ in mice, BDCA3+ in humans, and CD26+ in sheep, and is highly conserved among vertebrates. XCR1 mediates chemotaxis, increases intracellular calcium, and is crucial for efficient antigen cross-presentation and induction of cytotoxic CD8+ T cell responses, thus supporting both the innate and adaptive immune systems. It has restricted tissue distribution and plays key roles in immune surveillance, controlling infection, and potentially in cancer immunotherapy. MIP-II is a known antagonist, and functional interaction sites between its ligand, XCL1, and XCR1 have been characterized structurally. No direct clinical drugs are approved that target XCR1, but the axis is being investigated as a potential immunotherapeutic and vaccine target, especially due to its role in selectively guiding DCs and T cell interactions.
Drugs or molecules that act on XCR1 typically modulate immune cell migration and activation by antagonizing or agonizing its interaction with its chemokine ligand XCL1, thereby modulating the immune response. Antagonists such as MIP-II can block receptor signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-C motif chemokine receptor 1 (XCR1).